OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Headache and Pain is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II	392
Is there a causal relationship between stress and migraine? Current evidence and implications for management	200
Interleukin-6 induces spatially dependent whole-body hypersensitivity in rats: implications for extracephalic hypersensitivity in migraine	136
Post-traumatic trigeminal neuropathy: correlation between objective and subjective assessments and a prediction model for neurosensory recovery	97
Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment i	91
Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension	79
The International Headache Congress – IHS and EHF joint congress 2021: late breaking abstracts	78
Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database	73
Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials	68
Development and validation of a novel model for characterizing migraine outcomes within real-world data	60
Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis	59
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study	56
Migraine patients in Germany - need for medical recognition and new preventive treatments: results from the PANORAMA survey	53
Altered effective connectivity in migraine patients during emotional stimuli: a multi-frequency magnetoencephalography study	52
Enhanced functional connectivity between habenula and salience network in medication-overuse headache complicating chronic migraine positions it within the addiction disorders: an ICA-based resting-st	50
Altered speech patterns in subjects with post-traumatic headache due to mild traumatic brain injury	44
Episodic headache with spontaneous hypothermia reveal Shapiro’s syndrome variant with effectiveness of clonidine therapy	43
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance	43
Tracking tDCS induced grey matter changes in episodic migraine: a randomized controlled trial	42
Osmophobia in primary headache patients: associated symptoms and response to preventive treatments	41
Interictal osmophobia is associated with longer migraine disease duration	40
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention	40
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy	38
Effect of dural inflammatory soup application on activation and sensitization markers in the caudal trigeminal nucleus of the rat and the modulatory effects of sumatriptan and kynurenic acid	38
Repeated oxytocin prevents central sensitization by regulating synaptic plasticity via oxytocin receptor in a chronic migraine mouse model	37

Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(−receptor) antibodies	37
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience	37
Selective denervation of the corrugator supercilii muscle for the treatment of idiopatic trigeminal neuralgia purely paroxysmal distributed in the supraorbital and suprathrochlear dermatomes	37
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis	36
Altered functional connectivity of the right caudate nucleus in chronic migraine: a resting-state fMRI study	35
Long term evaluation of a multidisciplinary trigeminal neuralgia service	34
Sphingosine-1 phosphate receptor 1 contributes to central sensitization in recurrent nitroglycerin-induced chronic migraine model	34
Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study	34
Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache	33